Recent News
On March 4, 2026 the company filed its Form 10-K and published its 2026 annual report. On March 12, 2026 and surrounding dates, filings and reports noted Board disclosures, including a board diversity matrix effective March 26, 2026. On February 23, 2026 the company’s CFO reported an open-market purchase totaling 10,000 shares at an average price near $46.65.
Technical Analysis
ADX / DI+/DI-: ADX at 15.06 indicates no dominant trend; DI+ shows a peak-and-reversal which signals bearish directional pressure, while DI- increasing confirms rising downside bias against the backdrop of a weak trend. These readings suggest limited breakout potential near term and greater likelihood of range-bound movement with downside skew.
MACD: MACD at 0.80 sits below its signal line (0.96) and the MACD trend is decreasing, which signals bearish momentum and limits upward follow-through until momentum re-accelerates above the signal line.
MRO: MRO at 31.35 sits positive, indicating price sits above the oscillator’s target and faces mean-reversion pressure; the MRO trend shows a peak-and-reversal, reinforcing the likelihood of near-term corrective pressure.
RSI: RSI at 55.6 with a peak-and-reversal indicates momentum loss from recent strength rather than an oversold condition; momentum fatigue supports consolidation around current levels.
Price vs Moving Averages, Bollinger Bands, Ichimoku: Closing price $50.37 sits below the 20-day average ($51.74) but above the 50-day ($48.78) and 200-day ($45.22) averages, implying short-term pressure above medium- and long-term support. Price lies just above the 1x lower Bollinger band ($50.29), and Ichimoku components (Tenkan/Kijun $49.48; Senkou A $47.47; Senkou B $48.14) place the price above the cloud, which sustains medium-term technical support despite near-term momentum erosion.
Volume & Volatility Context: Recent volume (58,336) tracks slightly above the 10-day average (52,082) and well above the 200-day average (36,061), showing episodic interest; 42-day and 52-week volatility metrics at 2% indicate subdued absolute price swings relative to many peers, which favors orderly consolidation rather than violent moves.
Fundamental Analysis
Earnings & Estimates: For the quarter ending 2026-03-31 (report dated 2026-04-22), GAAP EPS came in at $1.41 versus an estimate of $1.29, an upside of $0.12 or a 9.30% EPS surprise. Forward EPS reads $1.3708 with a forward P/E of 34.51.
Earnings Growth: Reported earnings growth registers at 22.61% overall; sequential earnings growth (QoQ) shows a -3.39% change, while the year-over-year change shows -86.85% per the supplied YoY figure. These mixed periodic rates indicate stronger recent quarterly performance against a challenging year-over-year base.
Revenue & Cash Metrics: Revenue growth shows 6.46% overall; revenue growth QoQ registers -33.85% and revenue growth YoY -43.22%. Cash conversion cycle stands at 0 days, a year-over-year change of -1 day. Total invested capital reads $-98,280,000.
Capital, Credit Cost & Returns: Cost of debt equals 9.373%. Provision dynamics discussed on the earnings call included a modest release that contributed to quarterly profitability. Dividend policy continued with a declared quarterly payout following the quarter-end—management returned capital while reporting higher net income for the period.
Valuation Context: Trailing P/E at 34.70 sits above the industry peer median (approximately 29.68) but below the industry peer mean (approximately 51.95). PEG at 1.53 sits below the industry peer mean (approximately 2.71). WMDST values the stock as fair-valued; available analyst price targets show a mean target near $58.52 versus the close at $50.37, reflecting measured upside in consensus targets relative to the current valuation.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-03-31 |
| REPORT DATE: | 2026-04-22 |
| NEXT REPORT DATE: | 2026-07-22 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 1.29 | |
| EPS Actual | $ 1.41 | |
| EPS Difference | $ 0.12 | |
| EPS Surprise | 9.302 % | |
| Forward EPS | $ 1.37 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 34.7 | |
| Price To Earnings QoQ | -13.918 % | |
| Price To Earnings YoY | 1.201 % | |
| Price To Earnings IPRWA | high: 69.149 mean: 51.946 BWFG: 34.7 median: 29.685 low: 29.103 |
|
| PE/G Ratio | 1.535 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 34.509 | |
| Forward PE/G | 1.526 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 0.0 | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | -100.0 % | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -98.28 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 9.373 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 6.46 % | |
| Revenue Growth QoQ | -33.852 % | |
| Revenue Growth YoY | -43.224 % | |
| Revenue Growth IPRWA | high: 13.949 % mean: 7.803 % BWFG: 6.46 % median: -4.482 % low: -16.051 % |
|
| Earnings Growth | 22.609 % | |
| Earnings Growth QoQ | -339.274 % | |
| Earnings Growth YoY | -86.846 % | |
| Earnings Growth IPRWA | BWFG: 22.609 % high: 20.588 % mean: 9.944 % median: -11.538 % low: -22.5 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | — | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |